Oral insulin composition and methods of making and using thereof
AssigneeTechnology Development Corporation
InventorVladimir SABETSKY
Life of this patent
Estimating the term…
Abstract
A method of lowering blood glucose in a mammal includes orally administering a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin.
Claims12
An implant produced by providing a liquid composition comprising an aqueous solution of dextran with a molecular weight of 1.0 to 200 kDa at a concentration of 40-65% by weight to a mammal by introducing the liquid composition into the body of the mammal, thereby forming an implant in the body of the mammal.
Dependencies are inferred from the claim text.